While both are valuable in laboratory studies, their differences in receptor targeting provide unique opportunities for analyzing signaling pathways
They are especially beneficial for people with nutrient deficiencies or busy, active lifestyles
Hansson LE, Nyren O, Bergstrom R, et al
However, the new oral GLP-1 treatments contain the same active ingredients already used in existing injectable medications, which have undergone extensive clinical testing and have been used in diabetes treatment for years
Additionally, the effects of combined therapy appear to differ between major cardiovascular events and heart failure-related outcomes
Furthermore, although SGLT2is exhibited remarkable efficacy for reducing cardiovascular events, concerns were raised regarding the safety of these drugs in terms of limb events due to the increased incidence of amputations observed in the CANagliflozin cardioVascular Assessment Study (CANVAS) [10], with an almost twofold increase in risk